0001209191-24-003958.txt : 20240226
0001209191-24-003958.hdr.sgml : 20240226
20240226175434
ACCESSION NUMBER: 0001209191-24-003958
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duncan Barbara Gayle
CENTRAL INDEX KEY: 0001353128
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 24680728
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-22
0
0001636651
Ovid Therapeutics Inc.
OVID
0001353128
Duncan Barbara Gayle
C/O OVID THERAPEUTICS INC.
441 NINTH AVENUE
NEW YORK
NY
10001
1
0
0
0
0
Stock Option (Right to Buy)
3.68
2024-02-22
4
A
0
30000
0.00
A
2034-02-21
Common Stock
30000
30000
D
The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date.
/s/ Danielle Mann for Barbara Duncan by POA
2024-02-26